NLRP3 and brain ischemia: When specifically inhibiting the CKLF1/CCR4 axis, the activation of NLRP3 and the subsequent inflammatory response process could be further inhibited, thus protecting neurological function and improving cerebral ischemia (Ai et al., 2019).